BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30043238)

  • 1. Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.
    Mavrogeni SI; Sfikakis PP; Dimitroulas T; Koutsogeorgopoulou L; Markousis-Mavrogenis G; Poulos G; Kolovou G; Theodorakis G; Kitas GD
    Rheumatol Int; 2018 Sep; 38(9):1615-1621. PubMed ID: 30043238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.
    Mavrogeni S; Petrou E; Kolovou G; Theodorakis G; Iliodromitis E
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):518-25. PubMed ID: 23324829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction.
    Mavrogeni SI; Sfikakis PP; Markousis-Mavrogenis G; Bournia VK; Poulos G; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Katsifis G; Boki K; Vartela V; Kolovou G; Theodorakis G; Kitas GD
    Int J Cardiol; 2019 Jun; 284():105-109. PubMed ID: 30404725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive imaging markers associated with sudden cardiac death.
    van der Bijl P; Delgado V; Bax JJ
    Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and imaging of heart failure in women with autoimmune rheumatic diseases.
    Mavrogeni SI; Markousis-Mavrogenis G; Koutsogeorgopoulou L; Dimitroulas T; Vartela V; Rigopoulos A; Noutsias M; Kolovou G
    Heart Fail Rev; 2019 Jul; 24(4):489-498. PubMed ID: 30830518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific organized substrates of ventricular fibrillation: comparison of 320-slice CT heart images in non-ischemic ventricular fibrillation subjects with non-ischemic sustained and non-sustained ventricular tachycardia subjects.
    Ozawa K; Funabashi N; Takaoka H; Uehara M; Kobayashi Y
    Int J Cardiol; 2013 Sep; 168(2):1472-8. PubMed ID: 23351787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
    Wu KC
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy.
    Leonardi S; Raineri C; De Ferrari GM; Ghio S; Scelsi L; Pasotti M; Tagliani M; Valentini A; Dore R; Raisaro A; Arbustini E
    Eur Heart J; 2009 Aug; 30(16):2003-10. PubMed ID: 19474054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
    Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance.
    Mavrogeni SI; Bacopoulou F; Apostolaki D; Chrousos GP
    Eur J Clin Invest; 2018 Jul; 48(7):e12955. PubMed ID: 29782639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tissue Doppler imaging for predicting ventricular arrhythmias and cardiovascular mortality in ischaemic cardiomyopathy.
    Biering-Sørensen T; Olsen FJ; Storm K; Fritz-Hansen T; Olsen NT; Jøns C; Vinther M; Søgaard P; Risum N
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):722-31. PubMed ID: 27084397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction.
    Daniłowicz-Szymanowicz L; Kaufmann D; Rozwadowska K; Kempa M; Lewicka E; Raczak G
    PLoS One; 2018; 13(5):e0196812. PubMed ID: 29723261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.